Publications

Publications

Filter Results: (31) Arrow Down

Show Results For

Page 1 of 31 Results →
  • 2019
  • Chapter

Characterizing the Drug Development Pipeline for Precision Medicines

By: Amitabh Chandra, Craig Garthwaite and Ariel Dora Stern
BOOK ABSTRACT: Personalized and precision medicine (PPM)—the targeting of therapies according to an individual’s genetic, environmental, or lifestyle characteristics—is becoming an increasingly important approach in health care treatment and prevention. The advancement... View Details
Keywords: Healthcare; Precision Medicine
Related
  • 06 Sep 2022
  • Research & Ideas

Curbing an Unlikely Culprit of Rising Drug Prices: Pharmaceutical Donations

Prescription drug costs continue to climb in the United States, but tightening a loophole in a federal law may help curb rising expenses, according to research published this week in Health Affairs. Efforts to control US health care... View Details
Keywords: by Ben Rand; Insurance; Health; Pharmaceutical
  • October 2013
  • Case

FasterCures: Removing Barriers to Treatments

By: Richard G. Hamermesh and James Weber

In mid-2013, as FasterCures celebrated its 10th anniversary as a center of the Milken Institute, Executive Director Margaret Anderson thought about what the organization should do to ensure it had even more impact in its next 10 years. FasterCures was a non-profit... View Details

Keywords: Health Care; Health Care Industry; Health Care Policy; Health Services; Healthcare; Healthcare Reform; Healthcare Ventures; Nonprofit; Non-profit Management; Not-for-profit; Incubator; Accelerator; Venture Philanthropy; Medical Services; Medical Solutions; Medical Research; Medical Treatment; Clinical Trials; Drug Reimbursement; Early Stage; Early Stage Research Funding; Early Stage Funding; Milken Institute; Michael Milken; David Baltimore; Partnering For Cures; National Institutes Of Health; Cancer Care In The U.S.; Cancer Care Services; Policy-making; Health Care and Treatment; Health; Health Testing and Trials; Entrepreneurship; Social Entrepreneurship; Nonprofit Organizations; Policy; Health Industry; United States; District of Columbia
Related
  • March 2014
  • Editorial

Limits on Use of Health Economic Assessments for Rare Diseases

By: Hanna I. Hyry, Ariel Dora Stern, Jonathan CP Roos and Timothy M. Cox
Funding of expensive treatments for rare ('orphan') diseases is contentious. These agents fare poorly on 'efficiency' or health economic measures, such as the QALY, because of high cost and frequently poor gains in quality of life and survival. We show that... View Details
Keywords: Cost; Health Disorders; Health Care and Treatment; Pharmaceutical Industry
Related
  • 2023
  • Article

Dynamic HTA for Digital Health Solutions: Opportunities and Challenges for Patient-Centered Evaluation

By: Jan B. Brönneke, Annika Herr, Simon Reif and Ariel D. Stern
Germany’s 2019 Digital Healthcare Act (Digitale-Versorgung-Gesetz, or DVG) created a number of opportunities for the digital transformation of the health care delivery system. Key among these was the creation of a reimbursement pathway for patient-centered digital... View Details
Keywords: Digital Transformation; Applications and Software; Product Development; Insurance; Policy; Health Industry; Germany
Related
  • 09 Aug 2016
  • First Look

August 9, 2016

https://www.hbs.edu/faculty/Pages/item.aspx?num=51304 The Impact of the Entry of Biosimilars: Evidence from Europe By: Scott Morton, Fiona, Ariel Dora Stern, and Scott Stern Abstract—Biologic drugs (therapeutic proteins or... View Details
Keywords: Sean Silverthorne
  • 10 Oct 2007
  • First Look

First Look: First Look: October 10

broad-based therapies. Instead, the focus should be on enrolling subpopulations, based on diagnostic testing, in trials of targeted drug treatments and on monitoring and assessing effectiveness after drugs... View Details
Keywords: Martha Lagace
  • 16 Dec 2014
  • First Look

First Look: December 16

Michael E., and Robert S. Kaplan Abstract—Improving provider incentives and reimbursement must become a central component in health care reform. Reimbursement through bundled payments-a single payment that... View Details
Keywords: Sean Silverthorne
  • Web

Propose an Independent Project - MBA

and method for reimbursement for appropriate project expenses should be agreed to by the organizations and the student team before the project is underway. While students are not compensated for independent projects, sponsoring... View Details
  • Web

Information Technology - Institute For Strategy And Competitiveness

Measure Outcomes & Cost for Every Patient Aligning Reimbursement with Value Systems Integration Geography of Care Information Technology Information Technology Information Technology To make the transformation to value-based health care... View Details
  • Web

Health Care - Faculty & Research

providing obesity patients with a less invasive option long before GLP-1 drugs became the latest craze. Selling Allurion's medical device across 60+ countries, he awaited FDA approval to bring his technology to patients in the US. As time... View Details
  • 15 Jul 2013
  • Research & Ideas

Five Imperatives for Improving Health Care

to be reimbursed very well by insurance companies, and they've set themselves up to do a lot of those particular procedures? "Those are two different scenarios, and we'd like to see more of the former than the latter." Promoting... View Details
Keywords: by Carmen Nobel; Health
  • 01 Sep 2023
  • News

Solving for Z

With nearly 20 years of experience as a senior human resources executive, Matthew Breitfelder (MBA 2002) has seen a lot of change in the corporate talent space. But what’s happening now looks like a tectonic generational shift. From his perch as global head of human... View Details
Keywords: Alexander Gelfand; Illustrations by Doug Chayka; Administration of Human Resource Programs; Government
  • Web

Technology & Innovation - Faculty & Research

drug development. The case begins as PAREXEL is pursuing an expensive globalization and IT strategy while many of its competitors focus on cost cutting. Over the prior 20 years, CEO Josef von Rickenbach had grown PAREXEL into a... View Details
  • Web

1.19 Immersive Field Courses (IFC) - MBA

Global Experience Office reserves the right to modify the course or deny a student’s choice of location(s) for coursework participation, whichever is the least-restrictive reasonable alternative. Drug & Alcohol Policy The HBS View Details
  • Web

Industry Information - Alumni

health policy, reimbursement and payment models, population health and care quality, technology and data analytics, workflow improvements, management tactics and more . Look for targeted news in industries like Biotech, Health IT and... View Details
  • 08 Dec 2003
  • Research & Ideas

Why Europe Lags in Pharmaceuticals and Biotech

worldwide pharmaceuticals spending, according to Food and Drug Administration Commissioner Mark McClellan.) One problem, several panelists noted, is that European healthcare systems do not reimburse the high... View Details
Keywords: by Sean Silverthorne; Biotechnology; Health; Pharmaceutical; Technology
  • 08 Apr 2009
  • Research & Ideas

Clayton Christensen on Disrupting Health Care

describe it—in a way that applies to health care or any industry—is innovation that transforms a product or service that historically has been very complicated and expensive into something that is affordable and simple to use. Q: In your book, you identify... View Details
Keywords: by Deborah Blagg; Health
  • 01 Sep 2008
  • News

Mara Aspinall

higher efficacy rate — 80 percent or more. Is 80 percent efficacy unusual for drugs currently on the market? Across all patients and diseases, drug efficacy averages 50 percent, so half the time they bring... View Details
Keywords: Deborah Blagg; Ambulatory Health Care Services; Health, Social Assistance
  • 01 Mar 2009
  • News

A New Approach to Health-Care Reform

that is affordable and simple to use. In your book, you identify fee-for-service reimbursement as a “runaway reactor” in accelerating the rise in health-care costs. Why is this system such a problem? By some estimates, 50 percent of all... View Details
Keywords: Deborah Blagg; Health, Social Assistance